GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,638,000 | -40.9% | 151,800 | +60.1% | 0.37% | -40.2% |
| Q4 2021 | $2,771,000 | +399.3% | 94,800 | +334.9% | 0.62% | +360.4% |
| Q3 2021 | $555,000 | -27.3% | 21,800 | 0.0% | 0.13% | -33.3% |
| Q2 2021 | $763,000 | -14.1% | 21,800 | 0.0% | 0.20% | -14.5% |
| Q1 2021 | $888,000 | -5.9% | 21,800 | 0.0% | 0.24% | -8.9% |
| Q4 2020 | $944,000 | -21.5% | 21,800 | 0.0% | 0.26% | -33.5% |
| Q3 2020 | $1,202,000 | +84.4% | 21,800 | +122.4% | 0.39% | +78.8% |
| Q2 2020 | $652,000 | +30.9% | 9,800 | 0.0% | 0.22% | -4.4% |
| Q1 2020 | $498,000 | -72.9% | 9,800 | -57.6% | 0.23% | -65.7% |
| Q4 2019 | $1,836,000 | +104.7% | 23,100 | +24.9% | 0.66% | +59.3% |
| Q3 2019 | $897,000 | -39.1% | 18,500 | -33.9% | 0.42% | -24.0% |
| Q2 2019 | $1,472,000 | -0.6% | 28,000 | 0.0% | 0.55% | -0.2% |
| Q1 2019 | $1,481,000 | +164.0% | 28,000 | +36.6% | 0.55% | +156.8% |
| Q2 2017 | $561,000 | -73.7% | 20,500 | -64.7% | 0.21% | -73.9% |
| Q1 2017 | $2,134,000 | – | 58,000 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |